{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:07:36Z","timestamp":1789834056288,"version":"4.0.1"},"reference-count":100,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2024,12,17]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>Cystic fibrosis (CF) treatment has revolutionised care over the past three decades with major advances in survival. Despite these advances, CF continues to create psychological and social challenges for people with CF (PWCF) throughout their life and is associated with worse health outcomes and higher healthcare costs. Anxiety and depression screening and management protocols are widely implemented within CF care; however, a much broader scope of psychosocial challenges exist which lack a standardised screening and management approach. The advent of CF transmembrane conductance regulator modulator therapies is transforming the psychosocial landscape for PWCF with new challenges and evolving psychosocial needs. What it means to have CF, the expectations, hopes and stressors are rapidly changing, and psychosocial care must keep pace if health outcomes are to be fully optimised. A symposium of international CF and psychosocial experts was convened in November 2022 to explore current and emerging issues in psychosocial health and identify opportunities and approaches to optimise psychosocial care. This state-of-the-art review summarises key symposium proceedings and highlights priorities for clinical practice and research in psychosocial health across the lifespan among PWCF. It also summarises state-of-the-art initiatives for screening and intervention to optimise CF psychosocial healthcare and patient outcomes.<\/jats:p>","DOI":"10.1136\/bmjresp-2024-002606","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T11:55:34Z","timestamp":1739188534000},"page":"e002606","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Psychosocial and mental health in cystic fibrosis in the modern era of care: time to evolve"],"prefix":"10.1136","volume":"12","author":[{"given":"Maggie","family":"Harrigan","sequence":"first","affiliation":[{"name":"The University of Western Australia Medical School, Perth, Western Australia, Australia"},{"name":"Institute for Respiratory Health, Perth, Western Australia, Australia"},{"name":"Cystic Fibrosis Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M","family":"Georgiopoulos","sequence":"additional","affiliation":[{"name":"Division of Child and Adolescent Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L","family":"Quittner","sequence":"additional","affiliation":[{"name":"Joe DiMaggio Cystic Fibrosis, Pulmonary and Sleep Center, Hollywood, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Child and Adolescent Psychiatry, State University of New York at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5089-7125","authenticated-orcid":false,"given":"Tonia A","family":"Douglas","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, South Brisbane, Queensland, Australia"},{"name":"Faculty of Medicine, Clinical Unit, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"2026010701501424000_12.1.e002606.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2020.05.002"},{"key":"2026010701501424000_12.1.e002606.2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/17476348.2021.1855980","article-title":"Development of elexacaftor - tezacaftor - ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis","volume":"15","author":"Middleton","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"2026010701501424000_12.1.e002606.3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026010701501424000_12.1.e002606.4","doi-asserted-by":"crossref","first-page":"110607","DOI":"10.1016\/j.jpsychores.2021.110607","article-title":"Social support and social isolation in adults with cystic fibrosis: An integrative review","volume":"150","author":"Gulledge","year":"2021","journal-title":"J Psychosom Res"},{"key":"2026010701501424000_12.1.e002606.5","doi-asserted-by":"crossref","DOI":"10.1080\/17482631.2022.2062820","article-title":"Living with cystic fibrosis during the COVID-19 pandemic: a social connectedness perspective","volume":"17","author":"Harrigan","year":"2022","journal-title":"Int J Qual Stud Health Well-being"},{"key":"2026010701501424000_12.1.e002606.6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/02739615.2021.1993228","article-title":"Delivery of cystic fibrosis psychosocial care across developmental stages","volume":"52","author":"Lynn","year":"2023","journal-title":"Child Health Care"},{"key":"2026010701501424000_12.1.e002606.7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10566-021-09648-8","article-title":"Parenting Between the Rules: How the Parents of Young People with Cystic Fibrosis in Canada Navigate Cross-Contamination Restrictions","volume":"51","author":"Moola","year":"2022","journal-title":"Child Youth Care Forum"},{"key":"2026010701501424000_12.1.e002606.8","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205983"},{"key":"2026010701501424000_12.1.e002606.9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2296","article-title":"Parental Depression and Pancreatic Enzymes Adherence in Children With Cystic Fibrosis","volume":"137","author":"Barker","year":"2016","journal-title":"Pediatrics"},{"key":"2026010701501424000_12.1.e002606.10","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-14-205","article-title":"Symptoms of depression impact the course of lung function in adolescents and adults with cystic fibrosis","volume":"14","author":"Fidika","year":"2014","journal-title":"BMC Pulm Med"},{"key":"2026010701501424000_12.1.e002606.11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2474"},{"key":"2026010701501424000_12.1.e002606.12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcf.2020.07.020","article-title":"Decreased survival in cystic fibrosis patients with a positive screen for depression","volume":"20","author":"Schechter","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.13","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207488"},{"key":"2026010701501424000_12.1.e002606.14","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/ppul.26400","article-title":"National integration of mental health screening and treatment into specialized care for cystic fibrosis: What predicts success?","volume":"58","author":"Quittner","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.10.002"},{"key":"2026010701501424000_12.1.e002606.16","first-page":"S74","article-title":"The demographics of adverse outcomes in cystic fibrosis","volume":"54 Suppl 3","author":"McGarry","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ccm.2023.03.011","article-title":"Aiming to Improve Equity in Pulmonary Health: Cystic Fibrosis","volume":"44","author":"Oates","year":"2023","journal-title":"Clin Chest Med"},{"key":"2026010701501424000_12.1.e002606.18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ppul.26916","article-title":"Me, myself, and I: A systematic review of cystic fibrosis and self-concept","volume":"59","author":"Harrigan","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.19","unstructured":"Guidelines for UK clinical psychology services in cystic fibrosis. 2024. Available: https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2024-07\/CF%20Trust%20Psychology%20Guidelines%20V5.pdf"},{"key":"2026010701501424000_12.1.e002606.20","first-page":"S107","article-title":"Promoting emotional wellness in children with CF, part II: Mental health assessment and intervention","volume":"56 Suppl 1","author":"Georgiopoulos","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.21","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26131"},{"key":"2026010701501424000_12.1.e002606.22","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/ppul.26419","article-title":"Procedural anxiety among children and adolescents with cystic fibrosis and their parents","volume":"58","author":"Kimball","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.23","first-page":"30","article-title":"Psychosocial needs and interventions for young children with cystic fibrosis and their families","volume":"46","author":"Li","year":"2023","journal-title":"Paediatr Respir Rev"},{"key":"2026010701501424000_12.1.e002606.24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jcf.2023.08.006","article-title":"Food insecurity screening and local food access: Contributions to nutritional outcomes among children and adults with cystic fibrosis in the United States","volume":"23","author":"Bailey","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073322","article-title":"A longitudinal study of the impact of social deprivation and disease severity on employment status in the UK cystic fibrosis population","volume":"8","author":"Taylor-Robinson","year":"2013","journal-title":"PLoS ONE"},{"key":"2026010701501424000_12.1.e002606.26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ccm.2022.06.014","article-title":"Management of Mental Health in Cystic Fibrosis","volume":"43","author":"Bathgate","year":"2022","journal-title":"Clin Chest Med"},{"key":"2026010701501424000_12.1.e002606.27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jcf.2022.12.008","article-title":"Medical traumatic stress in cystic fibrosis: A qualitative analysis","volume":"22","author":"Cuneo","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.28","article-title":"Eating disorders and body image in cystic fibrosis","volume":"26","author":"Darukhanavala","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"2026010701501424000_12.1.e002606.29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ppul.26811","article-title":"Associations between symptoms of ADHD\/ODD and health outcomes in youth with cystic fibrosis","volume":"59","author":"Molitor","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2024.05.007","article-title":"Standards for the care of people with cystic fibrosis (CF); Planning for a longer life","volume":"23","author":"Gramegna","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jadohealth.2020.10.003","article-title":"Previsit Multidomain Psychosocial Screening Tools for Adolescents and Young Adults: A Systematic Review","volume":"68","author":"Glasner","year":"2021","journal-title":"J Adolesc Health"},{"key":"2026010701501424000_12.1.e002606.32","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2019.0158"},{"key":"2026010701501424000_12.1.e002606.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80056-8"},{"key":"2026010701501424000_12.1.e002606.34","doi-asserted-by":"crossref","unstructured":"Muther E , Lyons E , Vigers T , et al . EPS2.04 expanding the cystic fibrosis mental health screening guidelines: using the pediatric symptom checklist to identify and treat mental health symptoms in children 4\u201311 years of age. European Cystic Fibrosis Conference; 2023","DOI":"10.1016\/S1569-1993(23)00305-3"},{"key":"2026010701501424000_12.1.e002606.35","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsg046"},{"key":"2026010701501424000_12.1.e002606.36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-3146"},{"key":"2026010701501424000_12.1.e002606.37","unstructured":"The everyone project. 2024. Available: https:\/\/www.aafp.org\/family-physician\/patient-care\/the-everyone-project.html"},{"key":"2026010701501424000_12.1.e002606.38","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/ppul.24414","article-title":"Assessing psychosocial risk in pediatric cystic fibrosis","volume":"54","author":"Filigno","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.39","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.937189","article-title":"Patient engagement in the development of CF-CBT: A cystic fibrosis-specific cognitive-behavioral intervention for adults","volume":"13","author":"Friedman","year":"2022","journal-title":"Front Psychol"},{"key":"2026010701501424000_12.1.e002606.40","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/ppul.26101","article-title":"Feasibility and acceptability of a CF-specific cognitive-behavioral preventive intervention for adults integrated into team-based care","volume":"57","author":"Friedman","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.41","unstructured":"Friedman DG . Preventing depression and anxiety: a randomized controlled trial of a CF-specific CBT intervention. 2024. Available: https:\/\/www.medifind.com\/articles\/clinical-trial\/4596138"},{"key":"2026010701501424000_12.1.e002606.42","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/ppul.26339","article-title":"Electronic screening for unmet social needs in a pediatric pulmonary clinic: Acceptability and associations with health outcomes","volume":"58","author":"Oates","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.43","unstructured":"ICF-PWR: internet-delivered cystic fibrosis mental health prevention, wellness, resource program. 2024. Available: https:\/\/icf-pwr.ca\/about-us"},{"key":"2026010701501424000_12.1.e002606.44","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26527"},{"key":"2026010701501424000_12.1.e002606.45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2024.01.005","article-title":"Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues","volume":"23","author":"Burgel","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.10.043"},{"key":"2026010701501424000_12.1.e002606.47","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jcf.2023.05.002","article-title":"Cystic fibrosis in a transformative era: Adapting to changing mental health needs","volume":"22","author":"Landau","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.48","doi-asserted-by":"crossref","DOI":"10.1177\/17534666241235054","article-title":"Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor combination: a 1-year observational study","volume":"18","author":"Blardone","year":"2024","journal-title":"Ther Adv Respir Dis"},{"key":"2026010701501424000_12.1.e002606.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2024.02.003"},{"key":"2026010701501424000_12.1.e002606.50","first-page":"11","article-title":"Longitudinal Study of Therapeutic Adherence in a Cystic Fibrosis Unit: Identifying Potential Factors Associated with Medication Possession Ratio","volume":"11","author":"Gir\u00f3n","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2026010701501424000_12.1.e002606.51","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(22)00336-8","article-title":"ePS6.10 A real-world study evaluating the impact of elexacaftor\/tezacaftor\/ivacaftor treatment on medication adherence in cystic fibrosis","volume":"21","author":"Sutton","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcf.2017.05.008","article-title":"Worsening anxiety and depression after initiation of lumacaftor\/ivacaftor combination therapy in adolescent females with cystic fibrosis","volume":"16","author":"McKinzie","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jcf.2023.01.015","article-title":"Suicide attempts in adolescents with cystic fibrosis on Elexacaftor\/Tezacaftor\/Ivacaftor therapy","volume":"22","author":"Arslan","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1179208","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on mental health of patients with cystic fibrosis","volume":"14","author":"Piehler","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026010701501424000_12.1.e002606.55","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00535-2022","article-title":"The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosis","volume":"9","author":"van der Heijden","year":"2023","journal-title":"ERJ Open Res"},{"key":"2026010701501424000_12.1.e002606.56","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000001014"},{"key":"2026010701501424000_12.1.e002606.57","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25859"},{"key":"2026010701501424000_12.1.e002606.58","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jcf.2022.12.007","article-title":"Lived experiences of people with cystic fibrosis that were not eligible for elexacaftor-tezacaftor-ivacaftor (ETI): A qualitative study","volume":"22","author":"Milo","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2021.1201"},{"key":"2026010701501424000_12.1.e002606.60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcf.2022.10.002","article-title":"Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis","volume":"22","author":"Southern","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.61","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000001019"},{"key":"2026010701501424000_12.1.e002606.62","unstructured":"The North American cystic fibrosis conference continuing education guide. 2024. Available: https:\/\/www.nacfconference.org\/continuing-education-credits"},{"key":"2026010701501424000_12.1.e002606.63","unstructured":"Integrating mental health into cystic fibrosis care. 2024. Available: https:\/\/medicine.iu.edu\/continuing-education\/specialized\/cystic-fibrosis"},{"key":"2026010701501424000_12.1.e002606.64","unstructured":"Living Well with Cytsic Fibrosis (LWWCF) . Contemporary psychosocial care in the CFTR modulator era - a LWWCF training program for CF MDTs. 2024. Available: https:\/\/lwwcf.com.au\/mdttraining"},{"key":"2026010701501424000_12.1.e002606.65","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24949"},{"key":"2026010701501424000_12.1.e002606.66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcf.2023.12.002","article-title":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","volume":"23","author":"Southern","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.67","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(24)00686-6","article-title":"P391 A national survey to inform feasibility of adding mental health variables to the Cystic Fibrosis Foundation Patient Registry","volume":"23","author":"Georgiopoulos","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.68","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hsw\/hlaa009","article-title":"Introduction to Cystic Fibrosis for Mental Health Care Coordinators and Providers: Collaborating to Promote Wellness","volume":"45","author":"Mueller","year":"2020","journal-title":"Health Soc Work"},{"key":"2026010701501424000_12.1.e002606.69","unstructured":"Schwartz Rounds and Membership . The schwartz centre. 2024. Available: https:\/\/www.theschwartzcenter.org\/programs\/schwartz-rounds"},{"key":"2026010701501424000_12.1.e002606.70","doi-asserted-by":"crossref","DOI":"10.1177\/23743735211014049","article-title":"Partnership Enhancement Program: Piloting a Communication Training Program for Cystic Fibrosis Care Teams","volume":"8","author":"George","year":"2021","journal-title":"J Patient Exp"},{"key":"2026010701501424000_12.1.e002606.71","unstructured":"Snell C . The cystic fibrosis stress questionnaire (CFSQ). North American Cystic Fibrose Conference; Philadelphia, Pennsylvania, 2022"},{"key":"2026010701501424000_12.1.e002606.72","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1439"},{"key":"2026010701501424000_12.1.e002606.73","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(22)00204-1","article-title":"WS09.04 Psychometric characteristics of the CF Coping Self-Efficacy (CF-CSE) scale","volume":"21","author":"Georgiopoulos","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.74","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(23)01387-5","article-title":"462 Cystic fibrosis mental health and wellness questionnaire\u2014factors and properties","volume":"22","author":"O\u2019Hayer","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.75","unstructured":"Assessing for distressing symptoms and palliative care needs through targeted conversations regarding cystic fibrosis (ADAPT-CF). Improving life with cystic fibrosis: a primary palliative care partnership. 2024. Available: https:\/\/improvinglifewithcf.mgh.harvard.edu"},{"key":"2026010701501424000_12.1.e002606.76","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10880-021-09825-w","article-title":"Assessing Psychosocial Distress in Cystic Fibrosis: Validation of the \u201cDistress in Cystic Fibrosis Scale\u201d","volume":"29","author":"Finlay","year":"2022","journal-title":"J Clin Psychol Med Settings"},{"key":"2026010701501424000_12.1.e002606.77","unstructured":"Study to examine mental health challenges of kids with cystic fibrosis. 2024. Available: https:\/\/www.buffalo.edu\/ubnow\/stories\/2024\/09\/smith-tides.html"},{"key":"2026010701501424000_12.1.e002606.78","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ppul.24574","article-title":"Resilience in adolescents and young adults with cystic fibrosis: A pilot feasibility study of the promoting resilience in stress management intervention","volume":"55","author":"Toprak","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.79","unstructured":"Your CF care team. 2024. Available: https:\/\/www.cff.org\/managing-cf\/your-cf-care-team"},{"key":"2026010701501424000_12.1.e002606.80","unstructured":"Care, M.G.H.a.M.I.f.I.i.P . Improving life with cystic fibrosis: a primary palliative care partnership. 2024. Available: https:\/\/improvinglifewithcf.mgh.harvard.edu\/"},{"key":"2026010701501424000_12.1.e002606.81","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/2374373520978875","article-title":"Transition Planning for Chronic Illnesses in the Time of COVID-19","volume":"7","author":"Hunt","year":"2020","journal-title":"J Patient Exp"},{"key":"2026010701501424000_12.1.e002606.82","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pedn.2014.06.011","article-title":"Evaluation of a multidimensional cystic fibrosis transition program: a quality improvement initiative","volume":"30","author":"Gravelle","year":"2015","journal-title":"J Pediatr Nurs"},{"key":"2026010701501424000_12.1.e002606.83","doi-asserted-by":"crossref","unstructured":"Friedman D , Quittner AL , Bruce A , et al . Results of a pilot study of CF-CBT-A: a coping skills program to promote emotional well-being for teens with cystic fibrosis. North American Cystic Fibrosis Conference; 2024, Boston, Massachusetts. doi:10.1016\/S1569-1993(24)01393-6","DOI":"10.1016\/S1569-1993(24)01393-6"},{"key":"2026010701501424000_12.1.e002606.84","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/ppul.26438","article-title":"Pilot of a therapist\u2010guided digital mental health intervention (eHealth CF\u2010CBT) for adults with cystic fibrosis","volume":"58","author":"Verkleij","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"2026010701501424000_12.1.e002606.85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcf.2020.11.013","article-title":"ACT with CF: A telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis","volume":"20","author":"O\u2019Hayer","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.86","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/S1569-1993(22)00988-2","article-title":"298 Co-designing an acceptance and commitment therapy telehealth group intervention for adolescents with cystic fibrosis","volume":"21","author":"Liu","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.87","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcf.2021.07.012","article-title":"Pilot RCT of a telehealth intervention to reduce symptoms of depression and anxiety in adults with cystic fibrosis","volume":"21","author":"Bathgate","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.88","unstructured":"Schechter MS . Project uplift to reduce anxiety and depression in CF patients. 2024. Available: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03139266"},{"key":"2026010701501424000_12.1.e002606.89","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-020-00739-2","article-title":"Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub","volume":"7","author":"Arden","year":"2021","journal-title":"Pilot Feasibility Stud"},{"key":"2026010701501424000_12.1.e002606.90","unstructured":"CF peer connect. 2024. Available: https:\/\/www.cff.org\/get-involved\/cf-peer-connect#what-is-cf-peer-connect"},{"key":"2026010701501424000_12.1.e002606.91","unstructured":"Addressing social risk factors in the community: a toolkit for cf care teams. 2022. Available: SDOH@cff.org"},{"key":"2026010701501424000_12.1.e002606.92","unstructured":"Australasian clinical practice guidelines for social work in cystic fibrosis. 2017. Available: https:\/\/www.cfnz.org.nz\/assets\/Uploads\/a83bd38070\/The-Australasian-Clinical-Practice-Social-Work-Guidelines-2017-FINAL.pdf"},{"key":"2026010701501424000_12.1.e002606.93","unstructured":"RightCare cystic fibrosis toolkit. 2024. Available: https:\/\/www.england.nhs.uk\/long-read\/rightcare-cystic-fibrosis-toolkit"},{"key":"2026010701501424000_12.1.e002606.94","unstructured":"Standards for the clinical care of children and adults with cystic fibrosis in the UK. 2024. Available: https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2024-08\/Standards%20for%20the%20clinical%20care%20of%20children%20and%20adults%20with%20cystic%20fibrosis%20in%20the%20UK%202024.pdf"},{"key":"2026010701501424000_12.1.e002606.95","unstructured":"Cystic fibrosis australia standards of care for cystic fibrosis. 2023. Available: https:\/\/www.cysticfibrosis.org.au\/wp-content\/uploads\/2024\/07\/TD_CFA_Standard-of-Care_Design_Refresh_2024.07.25.pdf"},{"key":"2026010701501424000_12.1.e002606.96","unstructured":"Prioritising research in mental health working group (PRIME), cystic fibrosis foundation. 2024. Available: https:\/\/www.cff.org\/researchers\/prioritizing-research-mental-health-working-group"},{"key":"2026010701501424000_12.1.e002606.97","unstructured":"National mental health advisory committee, cystic fibrosis foundation. 2024. Available: http:\/\/my.cff.org\/library"},{"key":"2026010701501424000_12.1.e002606.98","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcf.2024.08.007","article-title":"Cystic fibrosis foundation position paper: Redefining the CF care model","volume":"23","author":"Goetz","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.99","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcf.2024.09.011","article-title":"Cystic fibrosis foundation position paper: Redefining the cystic fibrosis care team","volume":"23","author":"Brown","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2026010701501424000_12.1.e002606.100","unstructured":"European cystic fibrosis society mental health in the era of CFTR modulators working group. 2024. Available: https:\/\/www.ecfs.eu\/mental-health-era-cftr-modulators-working-group"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-002606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:50:52Z","timestamp":1767779452000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-002606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,10]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjresp-2024-002606"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-002606","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}